Vertex Pharmaceuticals Inc Stock (VRTX) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 3.21%3,440.80 | 3,333.90 | 2,986.90 | 3,190.00 | 3,076.40 |
| Cost Of Revenue | 7.54%526.10 | 489.20 | 392.80 | 466.00 | 414.80 |
44.98%844.10 | 582.20 | 493.70 | - | - | |
| Selling, General, and Administrative | 44.98%844.10 | 582.20 | 493.70 | - | - |
| Costs And Expenses | 30.71%2,727.90 | 2,087.00 | 1,848.80 | 1,984.10 | 1,890.20 |
| Operating Income/Loss | 42.83%712.90 | 1,246.90 | 1,138.10 | 1,205.90 | 1,186.20 |
| Income/Loss From Continuing Operations Before Tax | 43.71%783.40 | 1,391.80 | 1,252.90 | 1,331.00 | 1,298.80 |
| Income Tax Expense/Benefit | 55.55%129.80 | 292.00 | 221.50 | 139.90 | 215.90 |
40.57%653.60 | 1,099.80 | 1,031.40 | 1,191.10 | 1,082.90 | |
| Attributable To Parent | 40.57%653.60 | 1,099.80 | 1,031.40 | 1,191.10 | 1,082.90 |
| Basic Average Shares | 0.08%253.50 | 253.70 | 254.10 | -0.70 | 255.60 |
| Diluted Average Shares | 255.20 | 255.20 | 256.30 | -0.60 | 257.60 |
| Basic Earnings Per Share | 40.55%2.58 | 4.34 | 4.06 | 4.69 | 4.24 |
| Diluted Earnings Per Share | 40.60%2.56 | 4.31 | 4.02 | 4.64 | 4.20 |